The goal of this proposal is to develop in vitro and in vivo models for the study of microbicide activity against Treponema pallidum (the causative agent of syphilis) and to utilize these systems to evaluate microbicidal preparations under consideration for sexually transmitted disease prevention. Our laboratory has used a tissue culture system that supports limited multiplication of T. pallidum to study the spirochete's physiology, growth requirements, and antimicrobial susceptibility.
In Specific Aim 1, this in vitro culture system will be used to screen microbicidal compounds for activity against T. pallidum and to determine their minimal inhibitory and bactericidal concentrations. Candidate compounds to be tested in this system include C31G, nonoxynol-9, gramicidin, and other agents likely to have treponemicidal activity. Information from these studies will be used to determine the effective concentration ranges of microbicides for use in in vivo activity of microbicides. An abraded skin model will permit the direct evaluation of the ability of microbicides to block transepidermal infection. A rabbit vaginal model will also be investigated as a means of evaluating the activity of microbicides in preventing infection by this route.
In Specific Aim 3, the human vaginal xenograft -SCID mouse model under development in Dr. kreider's laboratory will be examined for its ability to support the growth and pathogenesis of T. pallidum. If successful, this model could be used to confirm the ability of treponemicidal agents to present the infection of human vaginal tissue. The information resulting from this project will be combined with the results of the other projects in this proposal to design the best combination of microbicidal agents for the prevention of viral and bacterial sexually transmitted infections.

Project Start
1997-09-01
Project End
1998-08-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Pennsylvania State University
Department
Type
DUNS #
129348186
City
Hershey
State
PA
Country
United States
Zip Code
17033
Passic, Shendra R; Ferguson, Mary Lee; Catalone, Bradley J et al. (2010) Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1. Biomed Pharmacother 64:723-32
Pavlovic, Jelena; Floros, Joanna; Phelps, David S et al. (2008) Differentiation of xenografted human fetal lung parenchyma. Early Hum Dev 84:181-93
Beer, Brigitte E; Doncel, Gustavo F; Krebs, Fred C et al. (2006) In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories. Antimicrob Agents Chemother 50:713-23
Fang, L; Meyers, C; Budgeon, L R et al. (2006) Induction of productive human papillomavirus type 11 life cycle in epithelial cells grown in organotypic raft cultures. Virology 347:28-35
Hartmann, Sandra Urdaneta; Wigdahl, Brian; Neely, Elizabeth B et al. (2006) Biochemical analysis of human milk treated with sodium dodecyl sulfate, an alkyl sulfate microbicide that inactivates human immunodeficiency virus type 1. J Hum Lact 22:61-74
Deka, Srilekha; Vanover, Jennifer; Dessus-Babus, Sophie et al. (2006) Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells. Cell Microbiol 8:149-62
Hartmann, Sandra Urdaneta; Berlin, Cheston M; Howett, Mary K (2006) Alternative modified infant-feeding practices to prevent postnatal transmission of human immunodeficiency virus type 1 through breast milk: past, present, and future. J Hum Lact 22:75-88; quiz 89-93
Fang, L; Budgeon, L R; Doorbar, J et al. (2006) The human papillomavirus type 11 E1/E4 protein is not essential for viral genome amplification. Virology 351:271-9
Urdaneta, Sandra; Wigdahl, Brian; Neely, Elizabeth B et al. (2005) Inactivation of HIV-1 in breast milk by treatment with the alkyl sulfate microbicide sodium dodecyl sulfate (SDS). Retrovirology 2:28
Krebs, Fred C; Miller, Shendra R; Ferguson, Mary Lee et al. (2005) Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1. Biomed Pharmacother 59:438-45

Showing the most recent 10 out of 35 publications